CAS 85750-38-5
:Erocainide
Description:
Erocainide is a pharmaceutical compound classified as an antiarrhythmic agent, primarily used in the treatment of certain types of cardiac arrhythmias. It belongs to the class of drugs known as sodium channel blockers, which work by inhibiting the influx of sodium ions during the cardiac action potential, thereby stabilizing the cardiac membrane and reducing excitability. Erocainide is typically administered in its hydrochloride form and is known for its effectiveness in managing ventricular arrhythmias. The compound has a relatively low solubility in water, which can influence its bioavailability and pharmacokinetics. Its chemical structure includes an aromatic ring and an amine group, contributing to its pharmacological properties. Erocainide may exhibit side effects, including potential toxicity, which necessitates careful monitoring of plasma levels during treatment. As with many antiarrhythmic medications, it is essential to consider patient-specific factors, including existing health conditions and concurrent medications, to optimize therapeutic outcomes and minimize risks.
Formula:C22H33ClN2O
InChI:InChI=1/C22H33ClN2O/c1-17(2)25(18(3)4)14-7-15-26-24-22-9-6-5-8-20(22)16-19-10-12-21(23)13-11-19/h10-13,16-18H,5-9,14-15H2,1-4H3/b20-16+,24-22+
Synonyms:- Erocainide [INN]
- (E)-2-(p-Chlorobenzylidene)cyclohexanone (E)-O-(3-(diisopropylamino)propyl)oxime
- Unii-Ej9Qi3Q1Lt
- 3-({[(1E,2E)-2-(4-chlorobenzylidene)cyclohexylidene]amino}oxy)-N,N-di(propan-2-yl)propan-1-amine
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 1 products.
